Nifedipine Tablet, Extended Release
Product Images NDC 51655-407

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 51655-407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 407 52)

Label (51655 407 52)
Label for Nifedipine extended-release tablets, USP, 90 mg strength, oral dosage form. The label indicates a package containing 30 tablets and notes prescription use only. Manufactured or labeled by Northwind Health Company, LLC. Additional storage instructions and warnings about moisture and handling are visible.*
FDA Label Image

01 (Image 01)

01 (Image 01)
Chemical structure diagram of nifedipine, showing its molecular geometry with a dihydropyridine ring and substituted functional groups, including nitro and acetoxy moieties.*
FDA Label Image

02 (Image 02)

02 (Image 02)
A table comparing the percentage of adverse effects reported in patients taking Nifedipine extended-release tablets versus placebo. It lists the incidences of headache, fatigue, dizziness, constipation, and nausea in each group.*
FDA Label Image

03 (Image 03)

03 (Image 03)
A data table comparing the percentages of various adverse effects reported in a clinical study between Nifedipine Capsules and Placebo groups. Effects listed include dizziness, flushing, headache, weakness, nausea, muscle cramps, peripheral edema, nervousness, palpitations, dyspnea, and nasal congestion, with corresponding percentages for each group.*
FDA Label Image

04 (Image 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.